Found: 49
Select item for more details and to access through your institution.
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00919-2
- By:
- Publication type:
- Article
Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma Patients.
- Published in:
- Frontiers in Genetics, 2021, v. 11, p. N.PAG, doi. 10.3389/fgene.2021.663487
- By:
- Publication type:
- Article
Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 2, p. 213, doi. 10.1016/j.clgc.2023.01.004
- By:
- Publication type:
- Article
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.
- Published in:
- Nature Medicine, 2000, v. 6, n. 6, p. 652, doi. 10.1038/76225
- By:
- Publication type:
- Article
Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM Registry.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 93, doi. 10.1111/bjh.17131
- By:
- Publication type:
- Article
Development of a prognostic model for overall survival in multiple myeloma using the Connect<sup>®</sup> MM Patient Registry.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 602, doi. 10.1111/bjh.16139
- By:
- Publication type:
- Article
Disease-free survival following high dose or standard dose therapy in patients with amyloidosis.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 1, p. 153, doi. 10.1111/bjh.13656
- By:
- Publication type:
- Article
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2325, doi. 10.1007/s00277-021-04534-8
- By:
- Publication type:
- Article
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Proliferation of human hematopoietic bone marrow cells in simulated microgravity.
- Published in:
- In Vitro Cellular & Developmental Biology Animal, 2001, v. 37, n. 2, p. 73, doi. 10.1290/1071-2690(2001)037<0073:POHHBM>2.0.CO;2
- By:
- Publication type:
- Article
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 190, doi. 10.1111/ejh.14214
- By:
- Publication type:
- Article
Gastrointestinal Plasmacytoma Presenting as Gastrointestinal Bleeding.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 5, p. 309
- By:
- Publication type:
- Article
Weekly Bortezomib/Methylprednisolone is Effective and Well Tolerated in Relapsed Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 131
- By:
- Publication type:
- Article
Connect MM Registry as a national reference for United States multiple myeloma patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 35, doi. 10.1002/cam4.2656
- By:
- Publication type:
- Article
Observations of Second Primary Malignancy in Patients With Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 2, p. 113, doi. 10.1016/j.clml.2011.11.003
- By:
- Publication type:
- Article
Novel Combination Treatments Targeting Chronic Myeloid Leukemia Stem Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 2, p. 94, doi. 10.1016/j.clml.2011.10.003
- By:
- Publication type:
- Article
Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patients.
- Published in:
- Journal of Behavioral Medicine, 2018, v. 41, n. 2, p. 243, doi. 10.1007/s10865-017-9892-5
- By:
- Publication type:
- Article
The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e336, doi. 10.1016/j.clml.2024.05.021
- By:
- Publication type:
- Article
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003
- By:
- Publication type:
- Article
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 112, doi. 10.1016/j.clml.2022.11.008
- By:
- Publication type:
- Article
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. 149, doi. 10.1016/j.clml.2021.08.007
- By:
- Publication type:
- Article
P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S109, doi. 10.1016/S2152-2650(21)02263-1
- By:
- Publication type:
- Article
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of t(11;14) on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e74, doi. 10.1016/j.clml.2019.09.118
- By:
- Publication type:
- Article
Frequency of and Associations Amongst Baseline Cytogenetics in Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e75, doi. 10.1016/j.clml.2019.09.119
- By:
- Publication type:
- Article
A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e4, doi. 10.1016/j.clml.2019.09.006
- By:
- Publication type:
- Article
A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.146
- By:
- Publication type:
- Article
Overall Survival of Patients Post-Transplant: Study Results from Two Phase 3 Trials ASPIRE and ENDEAVOR.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S238, doi. 10.1016/j.clml.2018.07.127
- By:
- Publication type:
- Article
Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment Patterns From 2009-2015 in Patients With Newly Diagnosed Multiple Myeloma in the United States: A Report From the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e20, doi. 10.1016/j.clml.2017.03.035
- By:
- Publication type:
- Article
Health-Related Quality of Life (HRQoL) of Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM) Receiving Any or Lenalidomide (LEN) Maintenance After Autologous Stem Cell Transplant (ASCT) in the Connect® MM Disease Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e89, doi. 10.1016/j.clml.2017.03.160
- By:
- Publication type:
- Article
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM Registry.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Recognition of early mortality in multiple myeloma by a prediction matrix.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 915, doi. 10.1002/ajh.24796
- By:
- Publication type:
- Article
A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 7, p. 573, doi. 10.1002/ajh.22048
- By:
- Publication type:
- Article
In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMT<sup>P140K</sup>-Transduced Human G-CSF-Mobilized Peripheral Blood Cells.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 5, p. 1016, doi. 10.1016/j.ymthe.2005.11.017
- By:
- Publication type:
- Article
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0427-x
- By:
- Publication type:
- Article
Cognitive and Situational Precipitants of Loneliness Among Patients With Cancer: A Qualitative Analysis.
- Published in:
- Oncology Nursing Forum, 2016, v. 43, n. 2, p. 156, doi. 10.1188/16.ONF.156-163
- By:
- Publication type:
- Article
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 3, p. 313, doi. 10.1111/j.1365-2141.2010.08248.x
- By:
- Publication type:
- Article
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 5, p. 677, doi. 10.1111/j.1365-2141.2009.07892.x
- By:
- Publication type:
- Article
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 2, p. 164, doi. 10.1111/j.1365-2141.2009.07728.x
- By:
- Publication type:
- Article
Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21.
- Published in:
- Oncologist, 2007, v. 12, n. 1, p. 99, doi. 10.1634/theoncologist.12-1-99
- By:
- Publication type:
- Article
The Cancer Loneliness Scale and Cancer-related Negative Social Expectations Scale: development and validation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48327-9
- By:
- Publication type:
- Article
High‐dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 18, p. 3115, doi. 10.1002/cncr.35375
- By:
- Publication type:
- Article
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 20, p. 3751, doi. 10.1002/cncr.33771
- By:
- Publication type:
- Article
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis.
- Published in:
- ClinicoEconomics & Outcomes Research, 2023, v. 15, p. 673, doi. 10.2147/CEOR.S412079
- By:
- Publication type:
- Article